Admission Date:  [**2128-3-22**]              Discharge Date:   [**2128-3-24**]  Date of Birth:  [**2055-7-18**]             Sex:   M  Service: MEDICINE  Allergies: Morphine / Vicodin  Attending:[**First Name3 (LF) 3276**] Chief Complaint: fatigue and weakness  Major Surgical or Invasive Procedure: none  History of Present Illness: 72 y/o male with PMHx of NSCLC, PE, who presented to the ED on [**3-22**] with generally increasing fatigue and tachypnea.
His hematocrit was 26 from baseline around 30, and INR was 3.6 on admission.
He received FFP, 1 unit PRBC, and a dose of cefepime vanc.
Due to slightly low blood pressure, the patient was also given steroids and 1L NS and admitted to the [**Hospital Unit Name 153**].
Oncology came to meet with the patient and his family, and decided that focusing goals of care on comfort was most appropriate.
He was made DNR/DNI but medications were continued, and he was admitted to OMED.
He reports some right flank/back pain, [**9-6**] before receiving IV dialudid.
He started radiation therapy in [**11-2**] and started cycle 1 of cisplatin/etoposide in [**12-2**] and cycle 2 in [**1-4**].
He completed XRT [**2128-1-5**].
PET scan in [**2-3**] demonstrated metastatic disease to the adrenals, so he was changed to taxotere therapy in [**3-3**] which he tolerated reasonably well.
NSCLC- former smoker, originally presented to PCP [**10-2**] with cough x 1 mo., CXR with lg R-lung mass, CT showed right upper lobe posterior segment mass abutting the chest wall but not invading with an enlarged upper R paratracheal node and lower R paratracheal node, s/p TBNA of mediastinal LAD [**10-22**] showing highly atypical cells suggestive of NSCLC and CT-guided biopsy of the lung mass [**10-29**] confirming NSCLC, MRI brain negative for met, s/p 2 cycles of cisplatinum/etoposide + XRT (completed [**2128-1-5**]).
HTN- per son used to be on meds but has been normotensive 3.
Pertinent Results: [**2128-3-22**] 11:15AM   PT-33.4* PTT-33.5 INR(PT)-3.6* [**2128-3-22**] 11:15AM   WBC-26.3* RBC-3.18* HGB-9.6* HCT-30.5* MCV-96 MCH-30.3 MCHC-31.5 RDW-20.1* [**2128-3-22**] 11:15AM   NEUTS-75* BANDS-9* LYMPHS-3* MONOS-9 EOS-2 BASOS-0 ATYPS-1* METAS-0 MYELOS-1* [**2128-3-22**] 11:53AM   LACTATE-2.3* [**2128-3-22**] 04:46PM   CK-MB-NotDone cTropnT-<0.01 [**2128-3-22**] 12:55PM   GLUCOSE-137* UREA N-24* CREAT-0.7 SODIUM-126* POTASSIUM-4.6 CHLORIDE-94* TOTAL CO2-22 ANION GAP-15 [**2128-3-22**] 11:36PM URINE  OSMOLAL-234  Brief Hospital Course:  72 y/o M with PMHx of NCSLC who presents with increased weakness and fatigue with progressive lung cancer.
Overnight, the patient had increased work of breathing and became diaphoretic and tachycardic and with the family and attending's involvement, the goal of care became comfort measures only.
Medications on Admission: Home meds: Pantoprazole Docusate Sodium 100 mg PO BID Senna 8.6 mg PO BID Acetaminophen 325 mg Hydromorphone 2 mg prn q4-6 Fentanyl 25 mcg/hr Patch 72HR Coumadin 2.5 mg/5mg alternate days qhs Florinef 0.1 decadron 4 qd .
Meds on Transfer HYDROmorphone (Dilaudid) 2-4 mg PO Q4-6H:PRN Dexamethasone 4 mg PO DAILY Docusate Sodium 100 mg PO BID Pantoprazole 40 mg PO Q24H Fentanyl Patch 50 mcg/hr TP Q72H Senna 1 TAB PO BID:PRN Fludrocortisone Acetate 0.1 mg PO DAILY   Discharge Medications: none  Discharge Disposition: Expired  Discharge Diagnosis: Non small cell lung cancer   Discharge Condition: expired   Discharge Instructions: n/a  Followup Instructions: n/a                                [**First Name8 (NamePattern2) 251**] [**Name8 (MD) **] MD [**MD Number(1) 3282**]
